In business for over 25 years, Chembio has been developing point-of-care (POC) diagnostic tests and technology for the detection of infectious diseases. Recently, Chembio developed a new and exciting platform for POC diagnostic tests that could transform the POC testing market. The new Dual Path Platform (DPP) surpasses traditional Lateral Flow technology with significantly increased analytical and clinical sensitivity, ability to run multip

Join for free to read